Gentaur Monalizumab – Anti-KLRC1 / NKG2A / CD159a Antibody

https://www.pathco.org/web/image/product.template/137752/image_1920?unique=6dd64d0
(0 review)
Recognizes inhibitory receptors on NK and CD8+ T-cells. Used to study immune evasion mechanisms in cancer and viral infection models.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 €

1,234,567.00 €

Not Available For Sale

This combination does not exist.


Internal Reference: GMA-KLRC1
Display Name: [GMA-KLRC1] Gentaur Monalizumab – Anti-KLRC1 / NKG2A / CD159a Antibody
Image 512: